Servier is an international independent pharmaceutical company that contributes to therapeutic progress in order to meet the needs of patients. With over 100 million patients worldwide receiving treatment with Servier's medications on a daily basis, the company focuses on key areas such as cardiovascular and metabolic disorders, oncology, and neuropsychiatric diseases. For over 30 years, Servier has been one of the leading European pharmaceutical companies in Russia.

Their medications are included in current